Showing 21 - 40 results of 334 for search '"viral hemorrhagic fever"', query time: 0.17s Refine Results
  1. 21
  2. 22
  3. 23

    Remote-controlled and pulse pressure-guided fluid treatment for adult patients with viral hemorrhagic fevers by Schultz, MJ, Deen, J, von Seidlein, L, Sivakorn, C, Kumar, A, Adhikari, NKJ, Wills, B, Kekulé, AS, Day, NPJ, Cooper, B, White, NJ, Salam, AP, Horby, P, Olliaro, P, Dondorp, AM

    Published 2021
    “…Circulatory shock, caused by severe intravascular volume depletion resulting from gastrointestinal losses and profound capillary leak, is a common clinical feature of viral hemorrhagic fevers, including Ebola virus disease, Marburg hemorrhagic fever, and Lassa fever. …”
    Journal article
  4. 24
  5. 25

    Factors affecting RIG-I-Like receptors activation - New research direction for viral hemorrhagic fevers by Paulina Małkowska, Paulina Małkowska, Paulina Niedźwiedzka-Rystwej

    Published 2022-09-01
    “…Viral hemorrhagic fever (VHF) is a term referring to a group of life-threatening infections caused by several virus families (Arenaviridae, Bunyaviridae, Filoviridae and Flaviviridae). …”
    Get full text
    Article
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections by Mark R. Hickman, David L. Saunders, Catherine A. Bigger, Christopher D. Kane, Patrick L. Iversen

    Published 2022-03-01
    “…The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure against deliberate use of high-consequence viral hemorrhagic fevers (VHFs) in 2016. The effort featured comprehensive preclinical research, including laboratory testing and rapid advancement of lead molecules into nonhuman primate (NHP) models of Ebola virus disease (EVD). …”
    Get full text
    Article
  11. 31

    The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections. by Mark R Hickman, David L Saunders, Catherine A Bigger, Christopher D Kane, Patrick L Iversen

    Published 2022-03-01
    “…The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure against deliberate use of high-consequence viral hemorrhagic fevers (VHFs) in 2016. The effort featured comprehensive preclinical research, including laboratory testing and rapid advancement of lead molecules into nonhuman primate (NHP) models of Ebola virus disease (EVD). …”
    Get full text
    Article
  12. 32
  13. 33
  14. 34
  15. 35
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40